Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CeraVe Itch Relief Moisturizing Lotion is an over-the-counter topical anesthetic and moisturizer developed by L'Oréal's CeraVe brand. Its primary active ingredient is 1% pramoxine hydrochloride, a small molecule topical anesthetic that provides rapid relief from itching (within 2 minutes) for up to 8 hours. The formulation is specifically designed for temporary relief of pruritus associated with minor skin irritations, insect bites, sunburn, poison ivy, and dry skin. In addition to its anesthetic properties, the lotion contains a blend of three essential ceramides (1, 3, and 6-II), hyaluronic acid, and niacinamide, which work synergistically to restore the skin's natural protective barrier and maintain hydration. It is steroid-free, fragrance-free, and non-comedogenic, making it suitable for sensitive and eczema-prone skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CeraVe Itch Relief Moisturizing Lotion.